Weihai Greatest Pharmaceutical Research Institute

Weihai Greatest Pharmaceutical Research Institute is a China-based biotechnology company focused on the research and development of innovative small molecule drugs. Located in the Weihai High-tech Industrial Development Zone, the institute specializes in therapeutic areas such as metabolic diseases, including type 2 diabetes and hyperuricemia. The company operates as an integrated R&D entity, managing projects from early-stage drug discovery through clinical development. Its portfolio includes several proprietary candidates currently undergoing clinical trials in China, aiming to provide improved treatment options for chronic metabolic conditions.